Interview - Pfizer Document: One of Five Stroke Sufferers Died Post-MRNA COVID Vaccine in the First 90 Days Following Rollout

Pfizer's conclusion: "This cumulative case review does not raise new safety issues."


Don't miss the latest interview with Dr. Naomi Wolf, War Room/DailyClout Pfizer Project Director Amy Kelly, and War Room/DailyClout volunteer and researcher, Chris Flowers, MD. In it, we discuss the War Room/DailyClout Pfizer Documents Analysis Project’s Team 1 Post-Marketing Group Stroke System Organ Class (SOC) Review, which is based on data in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“).

The stroke adverse events discussed were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom’s public rollout of Pfizer’s COVID-19 experimental mRNA “vaccine” product.

Read the original DailyClout report here.

Please Support DailyClout!

Become a DailyClout Member.


Share Behind the FDA Curtain: War Room/DailyClout Pfizer Reports